Overview

A Study of ASP1941 in Participants With Type 2 Diabetes Mellitus

Status:
Completed
Trial end date:
2009-03-14
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the efficacy, safety and pharmacokinetics of ASP1941 in male and female patients with type 2 diabetes mellitus
Phase:
Phase 2
Details
Lead Sponsor:
Astellas Pharma Inc
Treatments:
Ipragliflozin